Moderna Inc. (0A45)
LSE
Real-time Data
07:00 AM
Day's Range
182.4052 wk Range
22.25Overview - 0A45 - Moderna Inc.
Key Statistics
Valuation
Enterprise Value
23.28B
P/E (Trailing)
‪72.94‬
PEG Ratio
‪-9.71‬
Price / Sales (TTM)
‪8.92‬
Price / Book
‪4.39‬
EV / EBITDA
‪26.58‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪11.32%‬
Operating Margin
‪4.81%‬
Return on Assets
‪1.33%‬
Return on Equity
‪6.91%‬
Ownership
Shares Outstanding
399.00M
Float
343.43M
Held by Insiders
‪9.68%‬
Held by Institutions
‪69.48%‬
Price stats
Beta
‪1.64‬
50-Day Avg
‪107.74‬
200-Day Avg
‪64.36‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0A45 - Moderna Inc.
Peers - 0A45 - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation37.94BMarket Cap+23.65%52-week change0.24P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0A45 - Moderna Inc.
About
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, rare diseases, autoimmune conditions, and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
